               .            . T                                       212.


MTHFR POLYMORPHISM, HOMOCYSTEINE LEVELS AND PARKINSON’S DISEASE


      212 on MTHFR Mutation: A missing piece in the chronic disease puzzle.   T             .       T                              212.


          T              .        T                212.


  T  


on folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. T          folate                      .            2.


                  .                         2.


      . 2 sought to establish the effect of duration of PD on hyper- homocysteinemia. T                     T        . 2.                                        . 2.1


                .


      . 2 measured the level of cysteine and homocysteine in 90 patients with PD and with the MTHFR c677T (T/T) . T                  . T     TT  . T    T              T   2.


      . 2 reported that hypertrophy of IMC of carotid artery in Parkinson’s disease is associated with L-DOPA.    T . T               .                               .            .                      T   1  T     . 2.


                 T T      .


         2 248 T T 


    T  . 2 sought to clarify whether Levodopa treatment was necessary for homocysteine serum levels in PD patients with MTHFR C677T genotype. T       T T                            T  . 2.2


           T  . 2. T    T T                   .


PARK 7/ DJ -1 GENE AND PARKINSON’S DISEASE


1             .        2                 . 2.


     .


      .                       . 2.


        


        2 sought to understand the pathogenesis of PD    


THE ORIGINAL INTERNIST  21 T  T         T   


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52